M. Soulié, P. Coloby, J. Irani, T. Lebret, J. Patard et al., Recommandations de bonnes pratiques cliniques 2013 du CCAFU: Diagnostic, traitement et suivi des cancers urologiques chez l???homme et la femme, Progr??s en Urologie, vol.23, issue.2, pp.51-54, 2013.
DOI : 10.1016/S1166-7087(13)70046-0

H. Inoue, K. Nishimura, S. Yamaguchi, N. Nonomura, and T. Hara, Prostate-specific antigen measured 3??months after radical prostatectomy as a new predictor of biochemical recurrence, International Journal of Clinical Oncology, vol.59, issue.1, 2014.
DOI : 10.1007/s10147-014-0681-7

S. Buskirk, T. Pisansky, S. Schild, O. Macdonald, M. Wehle et al., Salvage Radiotherapy for Isolated Prostate Specific Antigen Increase After Radical Prostatectomy: Evaluation of Prognostic Factors and Creation of a Prognostic Scoring System, The Journal of Urology, vol.176, issue.3, pp.985-90, 2006.
DOI : 10.1016/j.juro.2006.04.083

A. Stephenson, P. Scardino, M. Kattan, T. Pisansky, K. Slawin et al., Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy, Journal of Clinical Oncology, vol.25, issue.15, pp.2035-2076, 2007.
DOI : 10.1200/JCO.2006.08.9607

G. Zagars and A. Pollack, Radiation therapy for T1 and T2 prostate cancer: Prostate-specific antigen and disease outcome, Urology, vol.45, issue.3, pp.476-83, 1995.
DOI : 10.1016/S0090-4295(99)80019-3

S. Cotter, M. Chen, J. Moul, W. Lee, B. Koontz et al., Salvage radiation in men after prostate?specific antigen failure and the risk of death. Cancer, pp.3925-3957, 2011.

M. Nielsen, B. Trock, and P. Walsh, Salvage or adjuvant radiation therapy: counseling patients on the benefits, J Natl Compr Cancer Netw JNCCN Feb, vol.8, issue.2, pp.228-265, 2010.

G. Grossfeld, J. Chang, J. Broering, D. Miller, Y. J. Flanders et al., IMPACT OF POSITIVE SURGICAL MARGINS ON PROSTATE CANCER RECURRENCE AND THE USE OF SECONDARY CANCER TREATMENT: DATA FROM THE CAPSURE DATABASE, The Journal of Urology, vol.163, issue.4, pp.1171-1177, 2000.
DOI : 10.1016/S0022-5347(05)67716-6

M. Blute, D. Bostwick, E. Bergstralh, J. Slezak, S. Martin et al., Anatomic site-specific positive margins in organconfined prostate cancer and its impact on outcome after radical prostatectomy, Urology, vol.50, issue.5, pp.733-742, 1997.
DOI : 10.1016/S0090-4295(97)00450-0

J. Eastham, K. Kuroiwa, M. Ohori, A. Serio, A. Gorbonos et al., Prognostic Significance of Location of Positive Margins in Radical Prostatectomy Specimens, Urology, vol.70, issue.5, pp.965-974, 2007.
DOI : 10.1016/j.urology.2007.08.040

J. Epstein, A. Partin, J. Sauvageot, and P. Walsh, Prediction of Progression Following Radical Prostatectomy, The American Journal of Surgical Pathology, vol.20, issue.3, pp.286-92, 1996.
DOI : 10.1097/00000478-199603000-00004

D. Paulson, Impact of radical prostatectomy in the management of clinically localized disease, J Urol, vol.152, issue.5, pp.1826-1856, 1994.

W. Catalona and D. Smith, CANCER RECURRENCE AND SURVIVAL RATES AFTER ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY FOR PROSTATE CANCER, The Journal of Urology, 1998.
DOI : 10.1097/00005392-199812020-00012

M. Han, A. Partin, C. Pound, J. Epstein, and P. Walsh, LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY, Urologic Clinics of North America, vol.28, issue.3, pp.555-65, 2001.
DOI : 10.1016/S0094-0143(05)70163-4

H. Zincke, J. Oesterling, M. Blute, E. Bergstralh, R. Myers et al., Long?term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer, J Urol, vol.152, issue.5 2, pp.1850-1857, 1994.

M. Choo, S. Cho, K. Ko, C. Jeong, S. Lee et al., Impact of positive surgical margins and their locations after radical prostatectomy: comparison of biochemical recurrence according to risk stratification and surgical modality, World Journal of Urology, vol.68, issue.4, 2013.
DOI : 10.1007/s00345-013-1230-0

A. Ochiai, T. Sotelo, P. Troncoso, V. Bhadkamkar, and R. Babaian, Natural History of Biochemical Progression After Radical Prostatectomy Based on Length of a Positive Margin, Urology, vol.71, issue.2, pp.308-320, 2008.
DOI : 10.1016/j.urology.2007.08.042

D. Cao, P. Humphrey, F. Gao, Y. Tao, and A. Kibel, Ability of Linear Length of Positive Margin in Radical Prostatectomy Specimens to Predict Biochemical Recurrence, Urology, vol.77, issue.6, 2011.
DOI : 10.1016/j.urology.2010.10.059

P. Sooriakumaran, A. Ploumidis, T. Nyberg, M. Olsson, O. Akre et al., The impact of length and location of positive margins in predicting biochemical recurrence after robotic?assisted radical prostatectomy with a minimum follow?up time of five years, BJU Int, 2013.

S. Kausik, M. Blute, T. Sebo, B. Leibovich, E. Bergstralh et al., Prognostic significance of positive surgical margins in patients with extraprostatic carcinoma after radical prostatectomy. Cancer, pp.1215-1224, 2002.

A. Stephenson, D. Wood, M. Kattan, E. Klein, P. Scardino et al., Location, Extent and Number of Positive Surgical Margins Do Not Improve Accuracy of Predicting Prostate Cancer Recurrence After Radical Prostatectomy, The Journal of Urology, vol.182, issue.4, pp.1357-63, 2009.
DOI : 10.1016/j.juro.2009.06.046

D. Cao, A. Kibel, F. Gao, Y. Tao, and P. Humphrey, The Gleason Score of Tumor at the Margin in Radical Prostatectomy is Predictive of Biochemical Recurrence, The American Journal of Surgical Pathology, vol.34, issue.7, 2010.
DOI : 10.1097/PAS.0b013e3181e103bf

F. Brimo, A. Partin, and J. Epstein, Tumor Grade at Margins of Resection in Radical Prostatectomy Specimens Is an Independent Predictor of Prognosis, Urology, vol.76, issue.5, 2010.
DOI : 10.1016/j.urology.2010.03.090

R. Savdie, L. Horvath, R. Benito, K. Rasiah, A. Haynes et al., High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy, BJU International, vol.25, issue.12, pp.1794-800
DOI : 10.1111/j.1464-410X.2011.10572.x

K. Udo, A. Cronin, L. Carlino, C. Savage, A. Maschino et al., Prognostic Impact of Subclassification of Radical Prostatectomy Positive Margins by Linear Extent and Gleason Grade, The Journal of Urology, vol.189, issue.4, pp.1302-1309
DOI : 10.1016/j.juro.2012.10.004

J. Huang, J. Pedersen, M. Hong, L. Harewood, J. Peters et al., Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer, BJU International, vol.5, issue.6 Pt 1, pp.921-928
DOI : 10.1111/j.1464-410X.2012.11665.x

M. Wang, L. Valenzuela, G. Murphy, and T. Chu, Purification of a human prostate specific antigen, The Journal of Urology, vol.167, issue.2, pp.960-964, 2002.
DOI : 10.1016/S0022-5347(02)80311-1

W. Catalona, D. Smith, T. Ratliff, K. Dodds, D. Coplen et al., Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer, New England Journal of Medicine, vol.324, issue.17, pp.1156-61, 1991.
DOI : 10.1056/NEJM199104253241702

D. Amico, A. Whittington, R. Malkowicz, S. Schultz, D. Schnall et al., A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer, J Urol, 1995.

P. Kupelian, J. Katcher, H. Levin, and E. Klein, State T1???2 prostate cancer: A multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy, International Journal of Radiation Oncology*Biology*Physics, vol.37, issue.5, pp.1043-52, 1997.
DOI : 10.1016/S0360-3016(96)00590-1

E. Kleer, J. Larson?keller, H. Zincke, and J. Oesterling, Ability of preoperative serum prostatespecific antigen value to predict pathologic stage and DNA ploidy Influence of clinical stage and tumor grade, Urology, vol.41, issue.3, pp.207-223, 1993.
DOI : 10.1016/0090-4295(93)90558-R

J. Oesterling, D. Chan, J. Epstein, A. Kimball, D. Bruzek et al., Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy, J Urol, vol.139, issue.4, pp.766-72, 1988.

J. Oesterling, Prostate-Specific Antigen, JAMA, vol.267, issue.16, pp.907-930, 1991.
DOI : 10.1001/jama.1992.03480160094042

H. Frazier, J. Robertson, P. Humphrey, and D. Paulson, Is prostate specific antigen of clinical importance in evaluating outcome after radical prostatectomy, J Urol, vol.149, issue.3, pp.516-524, 1993.

J. Mcneal, Cancer volume and site of origin of adenocarcinoma in the prostate: Relationship to local and distant spread, Human Pathology, vol.23, issue.3, pp.258-66, 1992.
DOI : 10.1016/0046-8177(92)90106-D

J. Barentsz, J. Richenberg, R. Clements, P. Choyke, S. Verma et al., ESUR prostate MR guidelines 2012, European Radiology, vol.19, issue.3 Pt 1, pp.746-57
DOI : 10.1007/s00330-011-2377-y

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3297750

S. Edge and C. Compton, The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, Annals of Surgical Oncology, vol.17, issue.6, 2010.
DOI : 10.1245/s10434-010-0985-4

G. Hull, F. Rabbani, F. Abbas, T. Wheeler, M. Kattan et al., CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTS, The Journal of Urology, vol.167, issue.2, pp.528-562, 2002.
DOI : 10.1016/S0022-5347(01)69079-7

S. Lerner, M. Blute, E. Bergstralh, D. Bostwick, J. Eickholt et al., Analysis of Risk Factors for Progression in Patients with Pathologically Confined Prostate Cancers After Radical Retropubic Prostatectomy, The Journal of Urology, vol.156, issue.1, pp.137-180, 1996.
DOI : 10.1016/S0022-5347(01)65967-6

A. Magheli, S. Rais?bahrami, H. Carter, H. Peck, J. Epstein et al., Subclassification of Clinical Stage T1 Prostate Cancer: Impact on Biochemical Recurrence Following Radical Prostatectomy, The Journal of Urology, vol.178, issue.4, pp.1277-1280, 2007.
DOI : 10.1016/j.juro.2007.05.153

A. Reese, M. Cooperberg, and P. Carroll, Minimal Impact of Clinical Stage on Prostate Cancer Prognosis Among Contemporary Patients With Clinically Localized Disease, The Journal of Urology, vol.184, issue.1, pp.114-123, 2010.
DOI : 10.1016/j.juro.2010.03.025

D. Gleason, Classification of prostatic carcinomas, Cancer Chemother Rep, vol.50, issue.3, pp.125-133, 1966.

L. Egevad, R. Mazzucchelli, and R. Montironi, Implications of the International Society of Urological Pathology Modified Gleason Grading System, Archives of Pathology & Laboratory Medicine, vol.136, issue.4, 2012.
DOI : 10.5858/arpa.2011-0495-RA

B. Delahunt, R. Miller, J. Srigley, A. Evans, and H. Samaratunga, Gleason grading: past, present and future, Histopathology, vol.54, issue.Suppl., pp.75-86, 2012.
DOI : 10.1111/j.1365-2559.2011.04003.x

B. Malavaud, X. Game, A. Villers, M. Mouzin, C. Mazerolles et al., Secondary biological recurrence after radical prostatectomy: multivariate analysis of prognostic clinical, biological, and histologic factors], Prog En Urol J Assoc Fr Urol Société Fr Urol, vol.11, issue.2, pp.277-82, 2001.

P. Pierorazio, P. Walsh, A. Partin, and J. Epstein, Prognostic Gleason grade grouping: data based on the modified Gleason scoring system, BJU International, vol.186, issue.5, pp.753-60, 2013.
DOI : 10.1111/j.1464-410X.2012.11611.x

D. Hernandez, M. Nielsen, M. Han, B. Trock, A. Partin et al., Natural History of Pathologically Organ-Confined (pT2), Gleason Score 6 or Less, Prostate Cancer After Radical Prostatectomy, Urology, vol.72, issue.1, pp.172-178, 2008.
DOI : 10.1016/j.urology.2007.10.055

F. Chun, M. Graefen, M. Zacharias, A. Haese, T. Steuber et al., Anatomic radical retropubic prostatectomy???long-term recurrence-free survival rates for localized prostate cancer, World Journal of Urology, vol.165, issue.4, pp.273-80, 2006.
DOI : 10.1007/s00345-006-0058-2

F. Pinto, T. Prayer?galetti, M. Gardiman, E. Sacco, M. Ciaccia et al., Clinical and Pathological Characteristics of Patients Presenting with Biochemical Progression after Radical Retropubic Prostatectomy for Pathologically Organ-Confined Prostate Cancer, Urologia Internationalis, vol.76, issue.3, pp.202-210, 2006.
DOI : 10.1159/000091619

M. Tefilli, E. Gheiler, R. Tiguert, W. Sakr, D. Grignon et al., Should Gleason score 7 prostate cancer be considered a unique grade category? Urology, 1999.

T. Chan, A. Partin, P. Walsh, and J. Epstein, Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy, Urology, vol.56, issue.5, pp.823-830, 2000.
DOI : 10.1016/S0090-4295(00)00753-6

M. Perrotti, F. Rabbani, P. Russo, M. Solomon, and W. Fair, Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors, Urology, vol.52, issue.1, 1998.
DOI : 10.1016/S0090-4295(98)00154-X

M. Ohori, J. Goad, T. Wheeler, J. Eastham, T. Thompson et al., Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol, pp.1843-1852, 1994.

M. Aihara, T. Wheeler, M. Ohori, and P. Scardino, Heterogeneity of prostate cancer inradical prostatectomy specimens, Urology, vol.43, issue.1, pp.60-66, 1994.
DOI : 10.1016/S0090-4295(94)80264-5

M. Adam, A. Hannah, L. Budäus, T. Steuber, G. Salomon et al., A Tertiary Gleason Pattern in the Prostatectomy Specimen and its Association with Adverse Outcome after Radical Prostatectomy, The Journal of Urology, vol.192, issue.1, 2014.
DOI : 10.1016/j.juro.2014.01.029

D. Whittemore, E. Hick, M. Carter, J. Moul, A. Miranda?sousa et al., Significance of Tertiary Gleason Pattern 5 in Gleason Score 7 Radical Prostatectomy Specimens, The Journal of Urology, vol.179, issue.2, pp.516-522, 2008.
DOI : 10.1016/j.juro.2007.09.085

C. Mosse, C. Magi?galluzzi, T. Tsuzuki, and J. Epstein, The Prognostic Significance of Tertiary Gleason Pattern 5 in Radical Prostatectomy Specimens, The American Journal of Surgical Pathology, vol.28, issue.3, 2004.
DOI : 10.1097/00000478-200403000-00014

T. Van-der-kwast, M. Amin, A. Billis, J. Epstein, D. Griffiths et al., International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume, Modern Pathology, vol.125, issue.1, pp.16-25, 2011.
DOI : 10.1111/j.1464-410X.2004.04555.x

J. Epstein, M. Carmichael, A. Partin, and P. Walsh, Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup, J Urol, 1993.

T. Stamey, J. Mcneal, C. Yemoto, B. Sigal, and I. Johnstone, Biological Determinants of Cancer Progression in Men With Prostate Cancer, JAMA, vol.281, issue.15, pp.1395-400, 1999.
DOI : 10.1001/jama.281.15.1395

M. Ohori, F. Abbas, T. Wheeler, M. Kattan, P. Scardino et al., PATHOLOGICAL FEATURES AND PROGNOSTIC SIGNIFICANCE OF PROSTATE CANCER IN THE APICAL SECTION DETERMINED BY WHOLE MOUNT HISTOLOGY, The Journal of Urology, vol.161, issue.2, pp.500-504, 1999.
DOI : 10.1016/S0022-5347(01)61935-9

J. Hansen, M. Bianchi, M. Sun, M. Rink, F. Castiglione et al., Percentage of high-grade tumour volume does not meaningfully improve prediction of early biochemical recurrence after radical prostatectomy compared with Gleason score, BJU International, vol.105, issue.Suppl., 2014.
DOI : 10.1111/bju.12424

J. Epstein, PATHOLOGIC ASSESSMENT OF THE SURGICAL SPECIMEN, Urologic Clinics of North America, vol.28, issue.3, pp.567-94, 2001.
DOI : 10.1016/S0094-0143(05)70164-6

J. Epstein, G. Pizov, and P. Walsh, Correlation of pathologic findings with progression after radical retropubic prostatectomy. Cancer, pp.3582-93, 1993.

L. Salomon, A. Anastasiadis, C. Johnson, J. Mckiernan, E. Goluboff et al., Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression, Urology, vol.62, issue.2, pp.304-313, 2003.
DOI : 10.1016/S0090-4295(03)00373-X

M. Ohori, P. Scardino, S. Lapin, C. Seale?hawkins, J. Link et al., The Mechanisms and Prognostic Significance of Seminal Vesicle Involvement by Prostate Cancer, The American Journal of Surgical Pathology, vol.17, issue.12, pp.1252-61, 1993.
DOI : 10.1097/00000478-199312000-00006

N. Sapre, J. Pedersen, M. Hong, L. Harewood, J. Peters et al., Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer, BJU International, vol.56, issue.4, pp.58-63, 2012.
DOI : 10.1111/j.1464-410X.2012.11477.x

A. Ayala, J. Ro, R. Babaian, P. Troncoso, and D. Grignon, The Prostatic Capsule, The American Journal of Surgical Pathology, vol.13, issue.1, pp.21-28, 1989.
DOI : 10.1097/00000478-198901000-00003

K. Roehl, M. Han, C. Ramos, J. Antenor, and W. Catalona, CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS, The Journal of Urology, vol.172, issue.3, pp.910-914, 2004.
DOI : 10.1097/01.ju.0000134888.22332.bb

T. Wheeler, O. Dillioglugil, M. Kattan, A. Arakawa, S. Soh et al., Clinical and pathological significance of the level and extent of capsular invasion in clinical stage T1???2 prostate cancer, Human Pathology, vol.29, issue.8, pp.856-62, 1998.
DOI : 10.1016/S0046-8177(98)90457-9

P. Tan, L. Cheng, J. Srigley, D. Griffiths, P. Humphrey et al., Working group 5: surgical margins, ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens, pp.48-57, 2011.

M. Blute, E. Bergstralh, A. Iocca, B. Scherer, and H. Zincke, USE OF GLEASON SCORE, PROSTATE SPECIFIC ANTIGEN, SEMINAL VESICLE AND MARGIN STATUS TO PREDICT BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY, The Journal of Urology, vol.165, issue.1, pp.119-144, 2001.
DOI : 10.1097/00005392-200101000-00030

S. Boorjian, R. Karnes, P. Crispen, R. Carlson, L. Rangel et al., The Impact of Positive Surgical Margins on Mortality Following Radical Prostatectomy During the Prostate Specific Antigen Era, The Journal of Urology, vol.183, issue.3, pp.1003-1012, 2010.
DOI : 10.1016/j.juro.2009.11.039

P. Swindle, J. Eastham, M. Ohori, M. Kattan, T. Wheeler et al., DO MARGINS MATTER? THE PROGNOSTIC SIGNIFICANCE OF POSITIVE SURGICAL MARGINS IN RADICAL PROSTATECTOMY SPECIMENS, The Journal of Urology, vol.174, issue.3, pp.903-910, 2005.
DOI : 10.1097/01.ju.0000169475.00949.78

C. Hawkins, E. Bergstralh, M. Lieber, and H. Zincke, Influence of dna ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy, Urology, vol.46, issue.3, pp.356-64, 1995.
DOI : 10.1016/S0090-4295(99)80220-9

O. Nativ, H. Winkler, Y. Raz, T. Therneau, G. Farrow et al., Stage C Prostatic Adenocarcinoma: Flow Cytometric Nuclear DNA Ploidy Analysis, Mayo Clinic Proceedings, vol.64, issue.8, 1989.
DOI : 10.1016/S0025-6196(12)61218-X

B. Montgomery, O. Nativ, M. Blute, G. Farrow, R. Myers et al., Stage B Prostate Adenocarcinoma, Archives of Surgery, vol.125, issue.3, pp.327-358, 1960.
DOI : 10.1001/archsurg.1990.01410150049010

M. Carmichael, R. Veltri, A. Partin, M. Miller, P. Walsh et al., Original Articles: Prostate Cancer: Deoxyribonucleic Acid Ploidy Analysis as a Predictor of Recurrence Following Radical Prostatectomy for Stage T2 Disease, The Journal of Urology, vol.153, issue.3, pp.1015-1024, 1995.
DOI : 10.1016/S0022-5347(01)67625-0

P. Humphrey, P. Walther, S. Currin, and R. Vollmer, Histologic Grade, DNA Ploidy, and Intraglandular Tumor Extent as Indicators of Tumor Progression of Clinical Stage B Prostatic Carcinoma, The American Journal of Surgical Pathology, vol.15, issue.12, pp.1165-70, 1991.
DOI : 10.1097/00000478-199112000-00007

E. Jones, J. Mcneal, N. Bruchovsky, and G. De-jong, DNA content in prostatic adenocarcinoma. A flow cytometry study of the predictive value of aneuploidy for tumor volume, percentage Gleason grade 4 and 5, and lymph node metastases. Cancer, pp.752-759, 1990.

T. Stamey, J. Mcneal, F. Freiha, and E. Redwine, Morphometric and clinical studies on 68 consecutive radical prostatectomies, J Urol, vol.139, issue.6, pp.1235-1276, 1988.

E. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, p.457, 1958.
DOI : 10.1214/aoms/1177731566

D. Cox, Partial likelihood, Biometrika, vol.62, issue.2, pp.269-76, 1975.
DOI : 10.1093/biomet/62.2.269

J. N. Eble, G. Sauter, J. I. Epstein, and I. Sesterhenn, World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, 2004.

B. Lennernäs, M. Edgren, M. Häggman, B. Norlén, and S. Nilsson, Postoperative Radiotherapy after Prostatectomy A Review, Scandinavian Journal of Urology and Nephrology, vol.37, issue.1, pp.10-15, 2003.
DOI : 10.1080/00365590310008613

T. Wiegel, D. Bottke, U. Steiner, A. Siegmann, R. Golz et al., Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95, Journal of Clinical Oncology, vol.27, issue.18, pp.2924-2954, 2009.
DOI : 10.1200/JCO.2008.18.9563

M. Bolla, H. Van-poppel, L. Collette, P. Van-cangh, K. Vekemans et al., Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911). Lancet, pp.572-580, 2005.

I. Thompson, . Jr, C. Tangen, J. Paradelo, M. Lucia et al., Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer, JAMA, vol.296, issue.19
DOI : 10.1001/jama.296.19.2329